Josep Montserrat-Capdevila1, Pere Godoy2,3, Josep Ramon Marsal4, Marta Ortega5, Josep Pifarré6, Miquel Alsedà2, Maria Teresa Castañ7, Ferran Barbé8. 1. Biomedical Research Institute (IRB) of Lleida, Catalan Institute of Health (ICS), UGA Terres de l'Urgell (Consultori Local de Bellvís-Els Arcs), Lleida, Catalonia, Spain. 2. Public Health Agency of Catalonia, Health Department, Biomedical Research Institute (IRB) of Lleida, University of Lleida, Faculty of Medicine, Lleida, Catalonia, Spain. 3. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. 4. Primary Care Research Institute (IDIAP) Jordi Gol, Universitat Autònoma of Barcelona, University Hospital Vall d'Hebron, Cardiovascular Department, Epidemiology Unit, Lleida, Catalonia, Spain. 5. Primary Care Research Institute (IDIAP) Jordi Gol, Universitat Autònoma of Barcelona, Catalan Institute of Health (ICS), Lleida, Catalonia, Spain. 6. University Hospital Santa Maria, Psychiatry Department, Biomedical Research Institute (IRB) of Lleida, University of Lleida, Faculty of Medicine, Lleida, Catalonia, Spain. 7. Biomedical Research Institute (IRB) of Lleida, Catalan Institute of Health (ICS), ABS Balaguer, Lleida, Catalonia, Spain. 8. University Hospital Arnau de Vilanova, Biomedical Research Institute (IRB) of Lleida, Respiratory Diseases Group, Biomedical Research Centre/Respiratory Diseases Network (CIBERES), Madrid, Spain.
Abstract
PURPOSE: Anxiety and depression are underdiagnosed in chronic obstructive pulmonary disease (COPD) patients. Few studies have tried to identify their association with hospitalization (severe exacerbation). The objective of this study was to determine whether the anxiety/depression was associated with severe exacerbation. DESIGN AND METHODS: A prospective cohort study, based on a sample of 512 patients diagnosed with COPD originating from primary care in a rural area in Lleida (Spain) and monitored between November 1, 2012 and October 31, 2014. For each patient, variables of interest were recorded; they were administered the HADS (Hospital Anxiety and Depression Scale) test to determine the possible presence of anxiety/depression, and its association with severe exacerbation was analyzed using a logistic regression model. FINDINGS: Initially, the prevalence of anxiety/depression was 15.6%. The incidence of global hospitalization in the first year was 8.2% and 11.3% in the second year. In patients with anxiety/depression, it increased to 17.5% in the first year and 18.8% in the second year. In the multivariate regression model, the diagnosis of anxiety/depression almost doubled the risk of hospitalization (OR = 1.94) (p < .041). PRACTICE IMPLICATIONS: Anxiety and depression are associated with an increased risk of hospitalization. Intervention studies are needed to evaluate the effects of anxiety/depression in the hospitalization.
PURPOSE:Anxiety and depression are underdiagnosed in chronic obstructive pulmonary disease (COPD) patients. Few studies have tried to identify their association with hospitalization (severe exacerbation). The objective of this study was to determine whether the anxiety/depression was associated with severe exacerbation. DESIGN AND METHODS: A prospective cohort study, based on a sample of 512 patients diagnosed with COPD originating from primary care in a rural area in Lleida (Spain) and monitored between November 1, 2012 and October 31, 2014. For each patient, variables of interest were recorded; they were administered the HADS (Hospital Anxiety and Depression Scale) test to determine the possible presence of anxiety/depression, and its association with severe exacerbation was analyzed using a logistic regression model. FINDINGS: Initially, the prevalence of anxiety/depression was 15.6%. The incidence of global hospitalization in the first year was 8.2% and 11.3% in the second year. In patients with anxiety/depression, it increased to 17.5% in the first year and 18.8% in the second year. In the multivariate regression model, the diagnosis of anxiety/depression almost doubled the risk of hospitalization (OR = 1.94) (p < .041). PRACTICE IMPLICATIONS: Anxiety and depression are associated with an increased risk of hospitalization. Intervention studies are needed to evaluate the effects of anxiety/depression in the hospitalization.
Authors: Marion J Wessels-Bakker; Eduard A van de Graaf; Johanna M Kwakkel-van Erp; Harry G Heijerman; Wiepke Cahn; Renske Schappin Journal: J Clin Nurs Date: 2021-07-02 Impact factor: 4.423